Učitavanje...
Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
BACKGROUND: There is evidence that implantable cardioverter‐defibrillator (ICD) for primary prevention in people with an ischaemic cardiomyopathy improves survival rate. The evidence supporting this intervention in people with non‐ischaemic cardiomyopathy is not as definitive, with the recently publ...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2018
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517305/ https://ncbi.nlm.nih.gov/pubmed/30537022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012738.pub2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|